ARGNF News and Press, Argen X SE

2026-06-24 01:32:09 ET argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis June 23, 2026 2:00 PM EDT... Read the full article on Seeking Alpha For further details see: argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn...

June 23, 2026, 7:00 AM CET Amsterdam, the Netherlands  – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will host a webinar titled “R&D Spotlight: Advancing FcRn Lea...

2026-06-18 15:28:24 ET The last time I spoke about Biohaven ( BHVN ) it was with a Seeking Alpha article entitled " Biohaven: Downgrade To Hold On Troriluzole Setback And Obesity Data 2nd Half 2026 ." With respect to this article, I mentioned that the company had achieved a comp...

2026-06-10 01:22:11 ET argenx SE (ARGX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 4:00 PM EDT... Read the full article on Seeking Alpha For further details see: argenx SE (ARGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference...

ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and consistent safety RHO+ data in Sjogren’s disease indicate maintenance of response following switch to biweekly dosing Cross-indication analysis of efgartigimod data across rheu...

May 28, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled “R&D Spotlight: Advancing FcRn Lea...

2026-05-27 15:16:00 ET The following segment was excerpted from the Baron Health Care Fund Q1 2026 Shareholder Letter . ... Read the full article on Seeking Alpha For further details see: Baron Health Care Fund Q1 2026 Portfolio Activity

2026-05-12 15:40:42 ET argenx SE (ARGX) Bank of America Global Healthcare Conference 2026 May 12, 2026 1:40 PM EDT... Read the full article on Seeking Alpha For further details see: argenx SE (ARGX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab positive, anti-MuSK-Ab positive, anti-LRP4-Ab positive, and triple seronegative Patients treated with VYVGART in the ADAPT SERON study experienced ra...

2026-05-07 17:12:10 ET More on argenx SE argenx SE (ARGX) Q1 2026 Earnings Call Transcript argenx SE: Excellent Company, Premium Valuation argenx SE 2025 Q4 - Results - Earnings Call Presentation argenx SE GAAP EPS of $5.52 beats by $0.31, revenue of $1.3B mi...